Delivery Order SPE2DB24D1205-SPE2DB24FCUXV
Award Date
9/20/24
Potential Completion Date
10/11/24
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $7,845.72, is for the delivery of Imbruvica 140 mg capsules over a period ending on March 20, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will supply this pharmaceutical product to support military treatment programs and facilities....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides Imbruvica 140 mg capsules to the Defense Logistics Agency (DLA). The $7,845.72 Firm Fixed Price delivery order was awarded on November 14, 2024, with a completion date of December 6, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,845.72 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 90 count bottles of IMBRUVICA 140 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of the drug Imbruvica (Ibrutinib) 140 mg capsules in quantities of 120. The $10,460.95 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major buying activity within the Department of Defense. This contract is not set-aside and has an ultimate completion date of October 31, 2024. AmerisourceBergen holds a large Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $7,322.67 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 MG TABLET 28S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation...
The U.S. Defense Logistics Agency (DLA) awarded a $21,968.01 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is to provide the medication IMBRUVICA 420 MG TABLET 28S, with a completion date of September 3, 2024. This represents a task order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen to supply a comprehensive range of pharmaceutical and medical products to support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for the supply of IMBRUVICA 140 MG CAPSULE 90S. The total ceiling value of the contract is $47,074.32 with a performance period through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA to provide pharmaceutical products and medical supplies to...
This is a $33,865.10 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,188,793 units of the drug Imbruvica 420 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through May 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $23,537.16 firm-fixed-price delivery order is for the drug Imbruvica 140 mg capsules, with a completion date of November 6, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
The U.S. government awarded a $7,322.67 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 280 MG TABLET 28S. This contract is a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a range of pharmaceutical products and...